Methyldopa is a medication used to treat high blood pressure, but it can also cause a type of anemia known as hemolytic anemia. Hemolytic anemia is a condition in which the body's red blood cells are destroyed faster than they can be replaced.
What Causes Hemolytic Anemia?
Hemolytic anemia can be caused by a number of different factors, including inherited conditions, infections, and certain medications. Methyldopa is one of the medications that can potentially cause hemolytic anemia. Other medications that have been linked to this condition include certain antibiotics, some chemotherapy drugs, and some medications used to treat heart arrhythmia.
How Does Methyldopa Cause Hemolytic Anemia?
The exact mechanism by which methyldopa causes hemolytic anemia is not fully understood. It is thought that the drug interferes with the production of red blood cells in the bone marrow, or that it causes the destruction of red blood cells.
Who is at Risk of Developing Hemolytic Anemia from Methyldopa?
Anyone taking methyldopa is at risk of developing hemolytic anemia. However, certain people may be more likely to develop this condition than others. People with a history of kidney or liver disease, diabetes, or anemia may be more likely to develop hemolytic anemia from methyldopa.
What are the Symptoms of Hemolytic Anemia?
The most common symptoms of hemolytic anemia include fatigue, shortness of breath, pale skin, and yellowing of the skin or eyes. If left untreated, hemolytic anemia can lead to more serious complications, such as heart failure.
What Should I Do if I Think I Have Hemolytic Anemia from Methyldopa?
If you think you may have hemolytic anemia from methyldopa, it is important to speak to your doctor as soon as possible. Your doctor can help diagnose the condition and work with you to develop a treatment plan that is right for you. Treatment may include discontinuing the medication, taking iron supplements, or undergoing a blood transfusion.
